Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Galloway, James C
LATITUDE-PsA-3002, NCT06671496: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Recruiting	3	600	Europe, Canada, Japan, US, RoW	Zasocitinib, TAK- 279, NDI-034858, Placebo	Takeda	Psoriatic Arthritis	05/27	01/28
NCT05890729: A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis	Recruiting	1/2	94	Europe, US, RoW	XTMAB-16 or Placebo	Xentria, Inc.	Pulmonary Sarcoidosis	04/26	04/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Galloway, James C
LATITUDE-PsA-3002, NCT06671496: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Recruiting	3	600	Europe, Canada, Japan, US, RoW	Zasocitinib, TAK- 279, NDI-034858, Placebo	Takeda	Psoriatic Arthritis	05/27	01/28
NCT05890729: A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis	Recruiting	1/2	94	Europe, US, RoW	XTMAB-16 or Placebo	Xentria, Inc.	Pulmonary Sarcoidosis	04/26	04/26